...cancer company Samumed LLC as CSO. He was CSO for tumor biology at the pharma. EpicentRx Inc....
...Staff Ferring Pharmaceuticals Inc. Samumed LLC ImmunoGen Inc. Spectrum Pharmaceuticals Inc. Prevail Therapeutics Inc. AxoGen Inc. Lonza Group Ltd. Moderna Inc. Immatics N.V. Sanifit Therapeutics S.A. EpicentRx Inc. Aligos...

...Francisco office. Ciechanover was president and CEO of Atara Biotherapeutics Inc. (NASDAQ:ATRA), which he founded. EpicentRx Inc....
...back to the immuno-oncology company's November $35 million series D (see "With $35M D Round, EpicentRx...
...effective January. She is VP of global government affairs at Indivior plc (LSE:INDV). BioCentury Staff insitro Inc. Polaris Partners EpicentRx Inc. Innovative...

...With a $35 million series D, EpicentRx hopes to take its immunotherapy through to an NDA...
...the sole investor in the round, which will be split into three tranches and give EpicentRx Inc....
...of runway, President and CEO Corey Carter told BioCentury. Launched in 2002, La Jolla, Calif.-based EpicentRx...

...NASDAQ:HOOK) hired Christine Baker as CBO and Roman Necina as CTO. Baker was CBO at EpicentRx Inc....

...colorectal cancer, small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) and neuroendocrine tumors. EpicentRx Inc....